IQVIA completed the acquisition of Pharmaspectra from Inflexion for $100m.

IQVIA, a health information company, completed the acquisition of Pharmaspectra, a provider of medical affairs data and analytics to the pharmaceutical and biotech industry, from Inflexion, a private equity firm, for $100m. "Pharmaspectra has seen significant growth over the past few years with the support of Inflexion. The business has invested in both its digital platform as well as its international operations, helping to attract a number of major new global clients. I look forward to continuing our growth journey," Jez Moulding, Pharmaspectra CEO.